Clinical trial

Aprepitant vs. Desloratadine in EGFR-TKIs Related Pruritus Treatment

NCT02646020

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2015-12-01

PhasePHASE2

Study timeline

Study start (unknown)2015-12-01Date precision: month

Registry last updated2021-05-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Non-small Cell Lung Cancerunresolved

Interventions

AprepitantDRUG · verified · RxNorm: aprepitant

DesloratadineDRUG · verified · RxNorm: desloratadine

Placebo of aprepitantDRUG

Placebo of desloratadineDRUG

Sponsors & collaborators

Sun Yat-sen Universitylead sponsor

Mapped research locations

GuangzhouGuangdong, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02646020 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.